Skip to main content
. Author manuscript; available in PMC: 2008 May 4.
Published in final edited form as: Int J Pharm. 2006 Nov 15;336(1):12–21. doi: 10.1016/j.ijpharm.2006.11.031

Figure 4.

Figure 4

Uptake of [14C]-erythromycin in the presence of unlabeled cyclosporine-A (25 and 50 μM) in rPCEC and SV40-HCEC. Each data point represents the mean ± SD of three determinations. Statistical significance was tested by two-factor ANOVA. *P ≤ 0.05; **P ≤ 0.01.